GlassScriptPhysician profile
Erin M Gullatt
NPI 1386061265
$11,181.48
in general payments reported to CMS, 2019-2025
42 companies · $692 in 2025
The $692 reported for 2025 was more than what 87% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $568 · 2020: $264 · 2021: $6,996 · 2022: $1,361 · 2023: $869 · 2024: $432 · 2025: $692.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,993.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,992.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,249.43 | 2019-2023 | Da Vinci Surgical System |
| Abbvie INC. | $511.23 | 2019-2025 | |
| Daiichi Sankyo INC. | $462.60 | 2020-2025 | Injectafer |
| Coloplast Corp | $396.56 | 2022-2024 | |
| Pfizer INC. | $347.06 | 2019-2025 | |
| Lupin INC. | $336.71 | 2019-2021 | |
| Evofem Biosciences, INC. | $257.65 | 2020-2023 | Phexxi |
| Avion Pharmaceuticals | $243.00 | 2020-2023 | Balcoltra |
| Hologic Sales and Service, LLC | $218.38 | 2020-2025 | Myosure Tissue Removal Device, Novasure, Aptima |
| Aspira Women'S Health INC | $192.73 | 2021-2022 | |
| Shield Therapeutics INC | $181.47 | 2022-2025 | |
| Astellas Pharma US INC | $172.63 | 2023-2025 | Veozah |
| Organon LLC | $155.25 | 2021-2025 | Nexplanon |
| Amgen INC. | $138.38 | 2019-2023 | Prolia, Evenity |
| Coopersurgical, INC. | $127.75 | 2019-2023 | Summit Doppler, Mara Console |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $118.52 | 2022-2025 | |
| Sage Therapeutics, LLC | $118.35 | 2022-2025 | Zurzuvae |
| Davol INC. | $111.88 | 2021-2024 | Arista Ah Flexitip |
| Exeltis, USA INC. | $91.73 | 2021-2025 | Slynd |
| Bayer Healthcare Pharmaceuticals INC. | $74.56 | 2019-2023 | |
| Becton, Dickinson and Company | $70.34 | 2022 | |
| Novo Nordisk INC | $67.14 | 2023-2024 | Wegovy |
| Lilly USA, LLC | $55.23 | 2025 | Mounjaro, Zepbound |
| Duchesnay USA Incorporated | $50.38 | 2019 | |
| Ethicon US, LLC | $41.18 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $34.15 | 2023-2024 | Myfembree |
| Merz North America, INC. | $33.55 | 2023 | Xeomin |
| Axsome Therapeutics, INC. | $33.19 | 2024-2025 | Auvelity |
| Amag Pharmaceuticals, INC. | $31.60 | 2019 | |
| Dexcom, INC. | $29.09 | 2025 | Dexcom G6 Transmitter |
| Therapeuticsmd, INC. | $26.03 | 2019-2020 | |
| Supernus Pharmaceuticals, INC. | $24.65 | 2025 | Qelbree |
| Innovation Technologies INC | $22.32 | 2025 | Irrisept |
| Axonics, INC. | $21.78 | 2023 | Bulkamid |
| Medicem INC. | $21.15 | 2020 | |
| Smith+Nephew, INC. | $19.39 | 2025 | Pico |
| Vertex Pharmaceuticals Incorporated | $17.90 | 2025 | |
| Roche Diagnostics Corporation | $16.85 | 2019 | |
| Lsi Solutions INC | $16.50 | 2024 | Fornisee |
| Currax Pharmaceuticals LLC | $14.88 | 2023 | Contrave |
| Myovant Sciences INC. | $14.77 | 2021 | |
| Allergan, INC. | $13.54 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erin Gullatt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.